| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0086 | 0.8 |